In in vivo experiments in mice, we could show that dissemination and tumor growth/weight were reduced in mice injected with TPC2 KO or Rab7a KO B16F10-luc melanoma cells as compared to WT B16F10-luc melanoma cell injection. Here, RAB7A is linked to neoplasm.